Skip Ribbon Commands
Skip to main content
Menu

Dr Suresh Rama Chandran

Dr Suresh Rama Chandran

MBBS, MRCP(UK)

Consultant

Specialty: Endocrinology

Sub-specialties: Diabetes, General Endocrinology

Conditions Treated by this Doctor:
Continuous Glucose Monitoring, General Endocrinology, Hyperthyroidism, Hypothyroidism, Insulin Pump Therapy, Lipid disorders, Pituitary disorders, Thyroid nodules, Thyroid Nodules, Type 1 Diabetes Mellitus (T1DM), Type 2 Diabetes Mellitus, Young Adults/Adolescent Diabetes.

Clinical Appointments

  • Consultant Endocrinology Singapore General HospitalSingapore General Hospital

Profile

Dr Suresh Rama Chandran is a Consultant with the Department of Endocrinology at the Singapore General Hospital. He graduated with honours in MBBS, 2004 from JIPMER, India; completed his post-graduate Internal Medicine training in 2009 and obtained MRCP (UK) in 2010. He completed his specialist training in Diabetes and Endocrinology at Singapore General Hospital in 2016. He completed a 1-year clinical research fellowship at the King’s College Hospital, London,  focussing on  the holistic care of people with type 1 diabetes and the use of technology to improve outcomes for people with type 1 diabetes while reducing the burden of self-care. His research interests are in the optimal use of continuous glucose monitoring and the integration of technology into the daily lives of people with diabetes to improve their care.

 

Education

  • MRCP (UK) (Endocrinology & Diabetes - SCE)
  • MD. DNB (Internal Medicine), India
  • MBBS

Professional Appointments and Committee Memberships

  • Clinical Lecturer, Yong Loo Lin School of MedicineJuly 2015 - present
  • Adjunct Instructor, DUKE-NUS Medical School, Singapore

Awards

  • ​MOH- Health Manpower Development - Fellowship Award, 2018
  • SingHealth Service with a Heart Award, 2018
  • Outstanding Resident Award – Diabetes & Endocrinology: 2014, 2015, 2016
  • Singapore Health Quality Services Award, 2013
  • Indian Council of Medical Research Award, 2004
  • Gold Medal in Internal Medicine – JIPMER, MBBS, 2003

Research Interests

  • Continuous glucose monitoring (CGM)
  • Continuous glucose monitoring derived glucose metrics
  • Technology to improve diabetes care
  • Psychology and Diabetes

Publications

  • Rama Chandran S, Zaremba N, Harrison A, Choudhary P, Cheah Y, Allan J, Debong F, Reid F, Treasure J, Hopkins D, Ismail K, Stadler M. Disordered eating in women with type 1 diabetes: Continuous glucose monitoring reveals the complex interactions of glycaemia, self-care behaviour and emotion. Diabet Med. 2020 Nov 3;:e14446. doi: 10.1111/dme.14446. [Epub ahead of print] PubMed PMID: 33141942.
  • Mattar SAM, Koh SJQ, Rama Chandran S, Cherng BPZ. Subacute thyroiditis associated with COVID-19. BMJ Case Rep. 2020 Aug 25;13(8). doi: 10.1136/bcr-2020-237336. PubMed PMID: 32843467; PubMed Central PMCID: PMC7449350.
  • Zhu L, Chandran SR, Tan WB, Xin X, Goh SY, Gardner DSL. Persistent Anxiety Is Associated with Higher Glycemia Post-Transition to Adult Services in Asian Young Adults with Diabetes. Diabetes Metab J. 2020 Jun 15;. doi: 10.4093/dmj.2019.0226. [Epub ahead of print] PubMed PMID: 32602276.
  • Rama Chandran S, Jacob P, Choudhary P. Baseline Glucose Variability and Interweek Variability Affects the Time to Stability of Continuous Glucose Monitoring-Derived Glycemic Indices. Diabetes Technol Ther. 2020 May 14;. doi: 10.1089/dia.2020.0011. [Epub ahead of print] PubMed PMID: 32223562.
  • P Jacob, S Rama Chandran, P Choudhary. (2019). 'The treatment of type 1 diabetes complicated by problematic hypoglycaemia'. In G. Orlando, L. Piemonti, C. Ricordi, R. J. Stratta, R. W. G. Gruessner (eds.) Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas (Edition 1, Volume 1, pp 391-406) London, United Kingdom, Academic Press.
  • Rama Chandran S, Vigersky R, Thomas A, Lim LL, Ratnasingam J, Tan A, S L Gardner D. Role of composite glycemic indices: A comparison of the Comprehensive Glucose Pentagon (CGP) across diabetes types and HbA1c levels. Diabetes Technol Ther. 2019 Sep 10;. doi: 10.1089/dia.2019.0277. [Epub ahead of print] [PMID: 31502876]
  • Rama Chandran S, Loh LM. The importance and implications of preconception genetic testing for accurate fetal risk estimation in 21-hydroxylase congenital adrenal hyperplasia (CAH). Gynecol Endocrinol. 2019 Jan;35(1):28-31. doi: 10.1080/09513590.2018.1490399. Epub 2018 Jul 25. [PMID: 30044156]
  • Rama Chandran S, Bhalshankar J, Farhad Vasanwala R, Zhao Y, Owen KR, Gardner DSL. Traditional clinical criteria outperform hs-CRP for the screening of HNF1A-MODY among young Asians with diabetes. Ther Adv Endocrinol Metab. 2018 Sep;9(9):271-282. doi: 10.1177/2042018818776167. eCollection 2018 Sep. PubMed PMID: 30181854; [PMC6116767]
  • Rama Chandran S, Tay WL, Lye WK, Lim LL, Ratnasingam J, Tan ATB, Gardner DSL. Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 Diabetes. Diabetes Technol Ther. 2018 May;20(5):353-362. doi: 10.1089/dia.2017.0388. Epub 2018 Apr 24. [PMID: 29688755]
  • Rama Chandran S, Balakrishnan RK. Images in clinical medicine. Müller's sign. N Engl J Med. 2013;369(15):e19 [PMID:24106957]
  • Chandran SR, Balakrishnan RK, Umakanthan K, Govindarajan K. Neurocysticercosis presenting as isolated WEMINO with Contraversive Ocular Tilt Reaction. J Neurosci Rural Pract. 2012 Jan; 3(1):84-6. [PMID:22346205]
  • Balakrishnan RK, Chandran SR, Thirumalnesan G, Doraisamy N. Thyrotoxic periodic paralysis. Indian J Endocr Metab 2011: 15; S147-9. [PMID:21966655]
  • Chandran SR, Vishnuram P. Hepatic profile of type 2 diabetes mellitus patients in a tertiary care hospital. J Assoc Physicians India. 2008 Aug;56:645. [PMID: 19051715]
  • Chandran SR, Rojith KB, Ramkumar N, Veerakesari S, Nedumaran, Umakanthan K. Askin's tumor. J Assoc Physicians India. 2009 May;57:393. [PMID: 19634286]

Research Trials